extracorporeal carbon dioxide removal

ECCO2R

An infrequently used treatment for severe hypercapnic respiratory failure (high carbon dioxide blood levels with accompanying respiratory acidosis), in which carbon dioxide is swept from venous blood and replaced, typically with oxygen.

References in periodicals archive ?

ALung provides low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure

ALung Technologies Forms Clinical Trial Steering Committee

Indeed, this artificial carbon dioxide removal was so efficient that, when extracorporeal carbon dioxide removal approximated carbon dioxide production, alveolar ventilation could almost be ceased (37).

Some of the devices evaluated for extracorporeal carbon dioxide removal include the Interventional Lung Assist (NovaLung GmbH, Hechingen, Germany) (40), arterio-venous extracorporeal carbon dioxide removal (41,42), low flow veno-venous extra-corporeal carbon dioxide removal (9), intra-venacaval oxygenation and carbon dioxide removal (43,44), intravascular lung assist (45), Hattler Respiratory Assist catheter (46), Decap (47) and Hemolung.

Carbon dioxide clearance in critical care

a provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, is participating in the world's first and largest pivotal trial of ECCO2R technology, the company said.

ALung's Artificial Lung Technology Chosen for Landmark Respiratory Failure Trial

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection.

Extracorporeal carbon dioxide removal using the Novalung in a patient with intracranial bleeding.

The management of extracorporeal carbon dioxide removal device in a diffuse alveolar haemorrhage

ALung makes low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, TODAY announced that it

Lung-Assist Device Maker ALung Receives CE Mark for Cartridge and Catheter Kits

We report the use of the Novalung[R] interventional Lung Assist extracorporeal carbon dioxide removal device, (Novalung GmbH, L otzenadcer 3, D-72379 Hechingen, Germany) to treat a 46-year-old female with life-threatening bronchospasm secondary to influenza infection.

The use of extracorporeal carbon dioxide removal in the management of life-threatening bronchospasm due to influenza infection

They compared extracorporeal carbon dioxide removal (ECC[O.

Extracorporeal carbon dioxide removal and low-frequency positive-pressure ventilation.

The role of extracorporeal membrane oxygenation for treatment of the adult respiratory distress syndrome: review and quantitative analysis